In order to maintain and strengthen the competitiveness of the Life Science industry in Sweden and the attractiveness of Sweden for Life Science projects, a national agenda for research and development within Life Science was initiated in September 2012 by the County Governor of Stockholm, Mr Chris Heister. The agenda – which goes under the operating name SILS (Sw. Sverige som Internationellt centrum för
Life Science) - aims to establish a domestic platform for interaction, and an agenda to support this platform, in order to ultimately increase Sweden’s competitiveness within the global Life Science arena. SILS includes participants from all the major Life Science regions in Sweden and is partly financed by Sweden’s Innovation Agency, VINNOVA. By making resources and expertise available, the project aims to help provide greater opportunities for individual participants in Sweden, as well as helping the entire Swedish Life Science sector in becoming more successful.
A proposal from SILS is expected in April 2013. The proposal will include a future research and development agenda with the ambition ultimately to (i) renew the primary focus of Swedish Life Science from healthcare to health promotion and prevention measures, (ii) increase exports and availability of funding and make Swedish research and development more attractive to businesses, and (iii) support the flow from research to development to manufacturing and through to sales.
SILS aims to initiate a substantial effort from all Life Science sector participants, including academy, industry, health care and authorities. It should be understood in the context of the Swedish Government’s commitment to strategic innovation areas, including increased annual appropriations by the government (announced in the Government Bill regarding research and innovation in October 2012, prop. 2012/13:30, and expected to be adopted by the Swedish Parliament before the end of February 2013).
Other articles related to the Life Sciences Update for February 2013: